Bill

Bill > SB1542


AZ SB1542

AZ SB1542
Controlled substances; approval; use; research


summary

Introduced
02/02/2026
In Committee
02/18/2026
Crossed Over
Passed
Dead

Introduced Session

Fifty-seventh Legislature - Second Regular Session (2026)

Bill Summary

AN ACT Amending title 23, chapter 6, article 4, Arizona Revised Statutes, by adding section 23-973; amending section 36-2511, Arizona Revised Statutes, as amended by laws 2021, chapter 61, section 12; amending section 36-2511, Arizona Revised Statutes, as amended by Laws 2025, chapter 231, section 1; amending title 36, chapter 27, article 2, Arizona Revised Statutes, by adding section 36-2517.03; appropriating monies; relating to controlled substances.

AI Summary

This bill, titled "Controlled substances; approval; use; research," aims to expand workers' compensation coverage for firefighters and certified peace officers diagnosed with post-traumatic stress disorder (PTSD) by potentially including a treatment protocol involving Midomafetamine, a controlled substance that must be approved by the U.S. Food and Drug Administration (FDA) and rescheduled by the U.S. Drug Enforcement Administration (DEA). The bill also appropriates $10 million for clinical trials, research, and training related to Midomafetamine for PTSD treatment, specifically targeting first responders and veterans. Importantly, the provisions related to Midomafetamine coverage and its inclusion as a controlled substance are contingent on FDA approval and DEA rescheduling by specific dates, with the Industrial Commission of Arizona tasked with establishing reimbursement guidelines once these conditions are met.

Committee Categories

Budget and Finance, Military Affairs and Security

Sponsors (1)

Last Action

Senate PS Committee action: Do Pass, voting: (6-1-0-0) (on 02/18/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...